Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Oxytocin alterations and neurocognitive domains in patients with hypopituitarism.

Eisenberg Y, Murad S, Casagrande A, McArthur M, Dugas LR, Barengolts E, Layden BT.

Pituitary. 2019 Jan 17. doi: 10.1007/s11102-019-00936-0. [Epub ahead of print]

PMID:
30656597
2.

Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice.

Khan MW, Priyadarshini M, Cordoba-Chacon J, Becker TC, Layden BT.

Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):678-687. doi: 10.1016/j.bbadis.2018.11.022. Epub 2018 Dec 10.

PMID:
30543855
3.

Hepatic HKDC1 Expression Contributes to Liver Metabolism.

Pusec CM, De Jesus A, Khan MW, Terry AR, Ludvik AE, Xu K, Giancola N, Pervaiz H, Daviau Smith E, Ding X, Harrison S, Chandel NS, Becker TC, Hay N, Ardehali H, Cordoba-Chacon J, Layden BT.

Endocrinology. 2019 Feb 1;160(2):313-330. doi: 10.1210/en.2018-00887.

PMID:
30517626
4.

Gut microbial features can predict host phenotype response to protein deficiency.

Navarro G, Sharma A, Dugas LR, Forrester T, Gilbert JA, Layden BT.

Physiol Rep. 2018 Dec;6(23):e13932. doi: 10.14814/phy2.13932.

5.

Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women.

Dugas LR, Bernabé BP, Priyadarshini M, Fei N, Park SJ, Brown L, Plange-Rhule J, Nelson D, Toh EC, Gao X, Dong Q, Sun J, Kliethermes S, Gottel N, Luke A, Gilbert JA, Layden BT.

Sci Rep. 2018 Nov 20;8(1):17135. doi: 10.1038/s41598-018-35230-9.

6.

More evening preference is positively associated with systemic inflammation in prediabetes and type 2 diabetes patients.

Nimitphong H, Mahattanapreut A, Chailurkit LO, Saetung S, Siwasaranond N, Sumritsopak R, Anothaisintawee T, Thakkinstian A, Dugas LR, Layden BT, Reutrakul S.

Sci Rep. 2018 Oct 26;8(1):15882. doi: 10.1038/s41598-018-34045-y.

7.

Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysis.

Adimadhyam S, Schumock GT, Calip GS, Smith Marsh DE, Layden BT, Lee TA.

Br J Clin Pharmacol. 2019 Jan;85(1):160-168. doi: 10.1111/bcp.13782. Epub 2018 Nov 8.

PMID:
30294925
8.

Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol.

Dugas LR, Lie L, Plange-Rhule J, Bedu-Addo K, Bovet P, Lambert EV, Forrester TE, Luke A, Gilbert JA, Layden BT.

BMC Public Health. 2018 Aug 6;18(1):978. doi: 10.1186/s12889-018-5879-6.

9.

Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT.

Compr Physiol. 2018 Jun 18;8(3):1091-1115. doi: 10.1002/cphy.c170050.

PMID:
29978895
10.

Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort study.

Adimadhyam S, Lee TA, Calip GS, Smith Marsh DE, Layden BT, Schumock GT.

Diabetes Obes Metab. 2018 Dec;20(12):2792-2799. doi: 10.1111/dom.13459. Epub 2018 Aug 5.

PMID:
29971914
11.

Autophagy Differentially Regulates Insulin Production and Insulin Sensitivity.

Yamamoto S, Kuramoto K, Wang N, Situ X, Priyadarshini M, Zhang W, Cordoba-Chacon J, Layden BT, He C.

Cell Rep. 2018 Jun 12;23(11):3286-3299. doi: 10.1016/j.celrep.2018.05.032.

12.

Gut Microbiota: FFAR Reaching Effects on Islets.

Priyadarshini M, Navarro G, Layden BT.

Endocrinology. 2018 Jun 1;159(6):2495-2505. doi: 10.1210/en.2018-00296. Review.

PMID:
29846565
13.

The Association of Dietary Fiber Intake with Cardiometabolic Risk in Four Countries across the Epidemiologic Transition.

Lie L, Brown L, Forrester TE, Plange-Rhule J, Bovet P, Lambert EV, Layden BT, Luke A, Dugas LR.

Nutrients. 2018 May 16;10(5). pii: E628. doi: 10.3390/nu10050628.

14.

Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.

Barengolts E, Green SJ, Eisenberg Y, Akbar A, Reddivari B, Layden BT, Dugas L, Chlipala G.

PLoS One. 2018 Mar 29;13(3):e0194171. doi: 10.1371/journal.pone.0194171. eCollection 2018.

15.

Inhibition of mTOR complexes protects cancer cells from glutamine starvation induced cell death by restoring Akt stability.

Khan MW, Layden BT, Chakrabarti P.

Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt A):2040-2052. doi: 10.1016/j.bbadis.2018.03.013. Epub 2018 Mar 17.

PMID:
29555211
16.

Studies on the Tissue Localization of HKDC1, a Putative Novel Fifth Hexokinase, in Humans.

Khan MW, Ding X, Cotler SJ, Clarke M, Layden BT.

J Histochem Cytochem. 2018 May;66(5):385-392. doi: 10.1369/0022155418756849. Epub 2018 Feb 5.

PMID:
29401404
17.

Oxytocin is lower in African American men with diabetes and associates with psycho-social and metabolic health factors.

Eisenberg Y, Dugas LR, Akbar A, Reddivari B, Layden BT, Barengolts E.

PLoS One. 2018 Jan 4;13(1):e0190301. doi: 10.1371/journal.pone.0190301. eCollection 2018.

18.

Homology modeling of FFA2 identifies novel agonists that potentiate insulin secretion.

Villa SR, Mishra RK, Zapater JL, Priyadarshini M, Gilchrist A, Mancebo H, Schiltz GE, Layden BT.

J Investig Med. 2017 Dec;65(8):1116-1124. doi: 10.1136/jim-2017-000523. Epub 2017 Aug 7.

19.

Incretin-Based Therapies: Revisiting Their Mode of Action.

Layden BT, Wicksteed B, Mauvais-Jarvis F.

Endocrinology. 2017 Jun 1;158(6):1560-1563. doi: 10.1210/en.2017-00252. No abstract available.

20.

Continuous Glucose Monitoring: A Perspective on Its Past, Present, and Future Applications for Diabetes Management.

Mariani HS, Layden BT, Aleppo G.

Clin Diabetes. 2017 Jan;35(1):60-65. doi: 10.2337/cd16-0008. No abstract available.

Supplemental Content

Loading ...
Support Center